CD161, a promising prognostic biomarker in hepatocellular carcinoma, correlates with immune infiltration
CD161 was identified as a promising prognostic biomarker for HCC, as its expression indicates a favorable prognosis. Additionally, CD161 is closely linked to high infiltration of immune cells, participates in the regulation of the tumor immune microenvironment, and holds promise as a potential biomarker for predicting the efficacy of immunotherapy.
Authors
- Man Zhao (ORCID: https://orcid.org/0000-0001-7368-1079)
- Guangjie Han (ORCID: https://orcid.org/0000-0002-6921-7369)
- Yuanyuan Wang (ORCID: https://orcid.org/0000-0002-7629-4178)
- Jinfeng Wang (ORCID: https://orcid.org/0000-0002-2568-2170)
- Xiaoxiao Wang (ORCID: https://orcid.org/0000-0002-3996-7900)
- Fei Yin (ORCID: https://orcid.org/0000-0003-2430-9267)
- Jianfei Shi (ORCID: https://orcid.org/0000-0002-4891-6689)
- Lili Mi
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-03-17
- DOI
- https://doi.org/10.7717/peerj.19055
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Natural Science Foundation of Hebei Province